936242-42-1

Basic information

• Product Name: (S)-2-((tert-butoxycarbonyl)amino)-4-pentynoic acid benzyl ester
• Synonyms: (S)-2-((tert-butoxycarbonyl)amino)-4-pentynoic acid benzyl ester
• CAS NO: 936242-42-1
• Molecular Weight: 303.358
• Mol File: 936242-42-1.mol
• Article Data: 15

Chemical Properties

• CAS DataBase Reference: (S)-2-((tert-butoxycarbonyl)amino)-4-pentynoic acid benzyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-2-((tert-butoxycarbonyl)amino)-4-pentynoic acid benzyl ester(936242-42-1)
• EPA Substance Registry System: (S)-2-((tert-butoxycarbonyl)amino)-4-pentynoic acid benzyl ester(936242-42-1)

Safety Data

• Hazardous Substances Data: 936242-42-1(Hazardous Substances Data)

Upstream product

• 108957-20-6 benzyl 2(S)-<(tert-butoxycarbonyl)amino>-3-iodopropionate 
• 100-39-0 benzyl bromide 
• 61172-66-5 (S)-2-(tert-butoxycarbonylamino)pent-4-ynoic acid 
• 100-44-7 benzyl chloride 
• 501-53-1 benzyl chloroformate 

Downstream Products

• 1007881-95-9 (S)-benzyl 3-(1-benzyl-1H-1,2,3-triazol-4-yl)-2-(methoxycarbonylamino)propanoate 
• 1401468-87-8 (S)-benzyl 2-(tert-butoxycarbonylamino)-5-(3,5-dichloropyridin-4-yl)pent-4-ynoate 
• 1401468-86-7 (S)-benzyl 2-(tert-butoxycarbonylamino)-5-(3,5-dibromopyridin-4-yl)pent-4-ynoate 
• 1364376-02-2 4,4'-{4-[(S)-4-benzyloxycarbonyl-4-(tert-butoxycarbonyl)aminobutyl]pyridin-3,5-diyl}di[(S)-2-(tert-butoxycarbonyl)aminobutanoic acid] 
• 1364375-98-3 benzyl (S)-2-(tert-butoxycarbonyl)amino-5-{3,5-bis[(S)-3-(tert-butoxycarbonyl)amino-4-hydroxybutyl]pyridin-4-yl}pentanoate 
• 1364375-94-9 benzyl (S)-2-(tert-butoxycarbonyl)amino-5-[3,5-bis(2-{[(S)-2,2-dimethyl-3-tert-butoxycarbonyl-1,3-oxazolidin-4-yl]ethyl})pyridin-4-yl]pentanoate 
• 1364376-34-0 benzyl 5-{5'-[4''-(S)-benzyloxycarbonyl-4''-(tert-butoxycarbonyl)aminobut-1''-ynyl]-4'-iodopyridin-3'-yl}-2-(S)-[(tert-butoxycarbonyl)amino]pent-4-ynoate 

Relevant articles and documents

Isoindoline compound, and preparation method, pharmaceutical composition and application thereof

The invention relates to a polysubstituted isoindoline compound represented by a general formula (I), and a preparation method, a pharmaceutical composition and an application thereof. Specifically, as a CRL4CRBNE3 ubiquitin ligase regulator with a novel structure, the polysubstituted isoindoline compound provided by the invention has stronger anti-tumor activity and an anti-tumor spectrum, and can be used for preparing medicines for treating diseases related to CRL4CRBNE3 ubiquitin ligase.

HEPATITIS C VIRUS INHIBITORS

The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

HEPATITIS C VIRUS INHIBITORS

The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.